Medical Marijuana Inc (OTCMKTS:MJNA) showing jumped of 1.33% and closed at $0.114, after gaining total volume of 5.56M shares. Its earnings per share (EPS) is $0.01 and its beta value stands at -1…69 points and has total market capitalization of $343.12 million and a total of 3.03 billion outstanding shares.
Medical Marijuana Inc (MJNA) on March 21, 2017 announced that its major investment company AXIM Biotechnologies, Inc. (AXIM Biotech) (AXIM), a world leader in cannabinoid research and development, has retained the services of Ora, Inc., a global Contract Research Organization (“CRO”), to perform the company’s upcoming product development (based on AXIM’ IP) and clinical trials for treating glaucoma and dry eye utilizing cannabinoid-based therapeutics. Ora is the world’s leading ophthalmology CRO for advancing products from pre-clinical through approval and post-market phases.
Ora will run the clinical programs under the supervision of Prof. Robert Ritch, Surgeon Director Emeritus and Chief of